Ligne de temps
Danielle PEREZ BERCOFF
Directeur(trice) Adjoint(e) de Centre National de Référence
06 oct. 2023
publication
Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern.
Lire plus19 févr. 2023
publication
Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone.
Lire plus12 juil. 2022
publication
Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone.
Lire plus26 nov. 2021
publication
TERT Promoter Mutations Increase Sense and Antisense Transcription from the TERT Promoter.
Lire plus12 avr. 2021
publication
Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus.
Lire plus19 mars 2020
01 sept. 2019
publication
Predominance of the heterozygous CCR5 delta-24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface.
Lire plus17 févr. 2018
publication
Reassessment of the capacity of the HIV-1 Env cytoplasmic domain to trigger NF-κB activation.
Lire plus01 janv. 2016
publication
The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission.
Lire plus16 nov. 2015
publication
Characteristics and spread to the native population of HIV-1 non-B subtypes in two European countries with high migration rate.
Lire plus27 juil. 2015
25 févr. 2015
01 janv. 2015
publication
Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe.
Lire plus01 oct. 2014
publication
COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification.
Lire plus02 sept. 2014
24 mai 2013
01 janv. 2013
publication
HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].
Lire plus01 mai 2012
publication
Automated sequence analysis and editing software for HIV drug resistance testing.
Lire plus01 déc. 2011
01 août 2011
publication
Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms.
Lire plus01 janv. 2011
publication
Impact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates.
Lire plus29 nov. 2010
01 oct. 2009
publication
Selective-advantage profile of human immunodeficiency virus type 1 integrase mutants explains in vivo evolution of raltegravir resistance genotypes.
Lire plus01 mai 2007
publication
Human immunodeficiency virus type 1: resistance to nucleoside analogues and replicative capacity in primary human macrophages.
Lire plus01 juil. 2003
publication
CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam.
Lire plus01 juin 2003
publication
Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.
Lire plus01 avr. 2003
publication
Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages.
Lire plus01 déc. 2002
publication